P-025 Synergistic antitumor activity of the BCMA 2+1 T-cell engager (TCE) alnuctamab (ALNUC; BMS-986349; CC-93269) and CELMoD agents in multiple myeloma (MM) preclinical models
Saved in:
Published in | Clinical lymphoma, myeloma and leukemia Vol. 23; pp. S46 - S47 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.09.2023
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 2152-2650 2152-2669 |
---|---|
DOI: | 10.1016/S2152-2650(23)01643-9 |